Also, we used an immunohistochemical (IHC) assay to analyze the expression of MYH9 in clinical tissue samples of lung cancer and found that it can be used as an independent factor in evaluating the prognosis of patients with NSCLC. The gene discussed is MYH9; the disease is non-small cell lung carcinoma.